Kadri Maegi-Lehtsi, general manager of Roche Pharmaceuticals Estonia, discusses the company’s established footprint in the Estonian market and their mission to give back to the Estonian society not only by providing innovative and highly needed medicines, but also through awareness and lifestyle campaigns.
In Estonia, Roche focuses on marketing and sales for oncology, virology, inflammation, central nervous system and metabolic disorder. How do you manage to have a leading position in the market despite tough competition?
"Our established footprint in the Estonian pharmaceutical market is primarily due to two factors: our products and our people."
